References
- 1. Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, et al. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2009, 30:1186-92.
- 2. Seifert H, Boullion B, Schulze A, Pulverer G. Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect Control Hosp Epidemiol. 1994; 15:520-8.
- 3. Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994; 12:1329-32.
- 4. Roberts SA, Findlay R, Lang SDR. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect. 2001; 48:228-32.10.1053/jhin.2001.0985
- 5. Yu YS, Yang Q, Xu XW, Kong HS, Xu GY, Zhong BY. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J Med Microbiol. 2004; 53:653-6.
- 6. Zarrilli R, Crispino M, Bagattini M. Molecular epidemilogy of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol. 2004; 42:946-53.10.1128/JCM.42.3.946-953.2004
- 7. Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis. 2008; 27:607-12.10.1007/s10096-008-0473-y
- 8. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis. 1005; 20:790-6.
- 9. Barbolla RE, Centron D, Maimone S, Rospide F, Salgueira C, Altclas J, et al. Molecular epidemiology of Acinetobacter baumannii spread in an adult intensive care unit under an endemic setting. Am J Infect Control. 2008; 36:444-52.10.1016/j.ajic.2007.09.010
- 10. Scerpella EG, Wanger AR, Armitige L, Anderlini P. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the casecontrol and molecular epidemiologic investigations. Infect Control Hosp. 1995; 16:92-7.
- 11. Houang ETS, Chu YW, Leung CM. Epidemiology and infection control implications of Acinetobcter spp. In Hong Kong. J Clin Microbiol. 2001; 39:228-34.
- 12. Maragakis LL, Cosgrove SE, Song X. An outbreak of multi-drug resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA. 2004; 292:3006-11.
- 13. Chu YW, Afzal-Shah M, Houang ET, Palepou ML, Lyon DJ, Woodford N. IMP-4, a novel metallo-b-lactamase from nosocomial Acinetobacter spp. Antimicrob Agents Chemother. 2001; 45:710-14.
- 14. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nuc Acids Res. 1990; 18:7213-18.
- 15. Seifert H, Schulze A, Baginski R, Pulverer G. Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J Clin Microbiol. 1994; 32:1816-19.
- 16. Koeleman JGM, Stoof J, Vandenbroucke-Gruls CM, Savelkoul PHM. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol. 2001; 39:8-13.10.1128/JCM.39.1.8-13.2001
- 17. Prashanth K, Badrinath S. Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR & pulse field gel electrophoresis. Indian J Med Res. 2005; 122:408-18.
- 18. Das I, Lamberty P, Hill D, Noy M, Bion J, Elliott T. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect. 2002; 50:110-14.
- 19. Killgore GE, Kato H. Use of arbitrary primer PCR to type Clostridium difficile and comparison of results with those by immunoblot typing. J Clin Microbiol. 1994; 32:1591-3.
- 20. Le Hello S, Falcot V, Lacassin F, Baumann F, Nordmann P, Naas T. Molecular epidemiology of carbapenemresistant Acinetobacter baumannii in New Caledonia. Clin Microbiol Infect. 2008; 14:977-81.
- 21. Lin MF, Yang CM, Lin CH, Huang ML, Tu CC, Liou ML. Clinical features and molecular epidemiology of multidrug-resistant Acinetobacter calcoaceticus-A baumannii complex in a regional teaching hospital in Taiwan. Am J Infect Control. 2009, 37:e1-3.
- 22. Wendt C, Dietze B, Dietz E, Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997; 35:1394-7.
- 23. Smolyakov R, Borer A, Riesenberg K. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect. 2003; 54:32-8.
- 24. Wang SH, Shengy WH, Chang YY. Healthcareassociated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care units. J Hosp Infect. 2003; 53:97-102.
- 25. Basustaoglu AC, Kisa O, Sacilik SC, Ozyurt M. Epidemiological characterization of hospital-acquired Acinetobacter baumannii isolates from a 1500-bed teaching hospital by phenotypic and genotypic methods. J Hosp Infect. 2001; 47:246-9.
- 26. Ayan M, Durmaz R, Aktas E, Durmaz B. Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital. J Hosp Infect. 2003; 54:39-45.10.1016/S0195-6701(03)00076-8